Goldman Sachs’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $5.22K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $30K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $57K | Hold |
|
|||||
|
2017
Q3 | $108K | Sell |
|
|||||
|
2017
Q2 | $452K | Buy |
|
|||||
|
2017
Q1 | $277K | Sell |
|
|||||
|
2016
Q4 | $440K | Sell |
|
|||||
|
2016
Q3 | $1.36M | Sell |
|
|||||
|
2016
Q2 | $1.93M | Sell |
|
|||||
|
2016
Q1 | $2.44M | Buy |
|
|||||
|
2015
Q4 | $684K | Buy |
|
|||||
|
2015
Q3 | $379K | Buy |
|
|||||
|
2015
Q2 | $183K | Buy |
|